Table of Contents Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2022, Forecast to 2027 1 Market Study Overview 1.1 Study Objectives 1.2 Chronic Obstructive Pulmonary Disorder (COPD) Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 Chronic Obstructive Pulmonary Disorder (COPD) Segment by Type 2.1.1 Corticosteroids 2.1.2 Phosphodiesterase Type 4 Inhibitors 2.1.3 Bronchodilators 2.1.4 Others 2.2 Market Analysis by Application 2.2.1 Hospital 2.2.2 Clinic 2.2.3 Retail Pharmacies 2.2.4 Other 2.3 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Comparison by Regions (2017-2027) 2.3.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2017-2027) 2.3.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Status and Prospect (2017-2027) 2.3.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Status and Prospect (2017-2027) 2.3.4 China Chronic Obstructive Pulmonary Disorder (COPD) Status and Prospect (2017-2027) 2.3.5 Japan Chronic Obstructive Pulmonary Disorder (COPD) Status and Prospect (2017-2027) 2.3.6 Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Status and Prospect (2017-2027) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2019 (Covid-19): Chronic Obstructive Pulmonary Disorder (COPD) Industry Impact 2.5.1 Chronic Obstructive Pulmonary Disorder (COPD) Business Impact Assessment - Covid-19 2.5.2 Market Trends and Chronic Obstructive Pulmonary Disorder (COPD) Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Manufacturer (2017-2022) 3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Manufacturer (2017-2022) 3.3 Global Chronic Obstructive Pulmonary Disorder (COPD) Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 Chronic Obstructive Pulmonary Disorder (COPD) Manufacturer Market Share 3.5 Top 10 Chronic Obstructive Pulmonary Disorder (COPD) Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into Chronic Obstructive Pulmonary Disorder (COPD) Market 3.7 Key Manufacturers Chronic Obstructive Pulmonary Disorder (COPD) Key Manufacturers 3.8 Mergers & Acquisitions Planning 4 Analysis of Chronic Obstructive Pulmonary Disorder (COPD) Industry Key Manufacturers 4.1 AstraZeneca 4.1.1 Compan Detail 4.1.2 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.1.3 AstraZeneca 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.1.4 Main Business Overview 4.1.5 AstraZeneca News 4.2 Boehringer Ingelheim International GmbH 4.2.1 Compan Detail 4.2.2 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.2.3 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.2.4 Main Business Overview 4.2.5 AstraZeneca News 4.3 GlaxoSmithKline 4.3.1 Compan Detail 4.3.2 GlaxoSmithKline Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.3.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.3.4 Main Business Overview 4.3.5 GlaxoSmithKline News 4.4 Novartis AG 4.4.1 Compan Detail 4.4.2 Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.4.3 Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.4.4 Main Business Overview 4.4.5 Novartis AG News 4.5 Teva Pharmaceutical Industries 4.5.1 Compan Detail 4.5.2 Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.5.3 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.5.4 Main Business Overview 4.5.5 Teva Pharmaceutical Industries News 4.6 Sunovion Pharmaceuticals 4.6.1 Compan Detail 4.6.2 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.6.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.6.4 Main Business Overview 4.6.5 Sunovion Pharmaceuticals News 4.7 CHIESI Farmaceutici 4.7.1 Compan Detail 4.7.2 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.7.3 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.7.4 Main Business Overview 4.7.4 Main Business Overview 4.8 Orion Corporation 4.8.1 Compan Detail 4.8.2 Orion Corporation Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.8.3 Orion Corporation Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.8.4 Main Business Overview 4.8.5 Orion Corporation News 4.9 ​Mylan 4.9.1 Compan Detail 4.9.2 ​Mylan Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification 4.9.3 ​Mylan Chronic Obstructive Pulmonary Disorder (COPD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.9.4 Main Business Overview 4.9.5 ​Mylan News 5 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Segment by Big Type 5.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Sales and Market Share by Big Type (2017-2022) 5.1.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales and Market Share by Big Type (2017-2022) 5.1.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Market Share by Big Type (2017-2022) 5.2 Corticosteroids Sales Growth Rate and Price 5.2.1 Global Corticosteroids Sales Growth Rate (2017-2022) 5.2.2 Global Corticosteroids Price (2017-2022) 5.3 Phosphodiesterase Type 4 Inhibitors Sales Growth Rate and Price 5.3.1 Global Phosphodiesterase Type 4 Inhibitors Sales Growth Rate (2017-2022) 5.3.2 Global Phosphodiesterase Type 4 Inhibitors Price (2017-2022) 5.4 Bronchodilators Sales Growth Rate and Price 5.4.1 Global Bronchodilators Sales Growth Rate (2017-2022) 5.4.2 Global Bronchodilators Price (2017-2022) 5.5 Others Sales Growth Rate and Price 5.5.1 Global Others Sales Growth Rate (2017-2022) 5.5.2 Global Others Price (2017-2022) 6 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Segment by Big Application 6.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Market Share by Big Application (2017-2022) 6.2 Hospital Sales Growth Rate (2017-2022) 6.3 Clinic Sales Growth Rate (2017-2022) 6.4 Retail Pharmacies Sales Growth Rate (2017-2022) 6.5 Other Sales Growth Rate (2017-2022) 7 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecast 7.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Sales and Growth Rate (2022-2027) 7.2 Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast by Regions (2022-2027) 7.2.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) 7.2.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) 7.2.3 China Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) 7.2.4 Japan Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) 7.2.5 Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) 7.2.6 Other Regions Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) 7.3 Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast by Type (2022-2027) 7.3.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Forecast by Type (2022-2027) 7.3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share Forecast by Type (2022-2027) 7.4 Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast by Application (2022-2027) 7.4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Forecast by Application (2022-2027) 7.4.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share Forecast by Application (2022-2027) 8 Market Analysis 8.1.1 Market Overview 8.1.2 Market Opportunities 8.1.3 Market Risk 8.1.4 Market Driving Force 8.1.5 Porter's Five Forces Analysis 8.1.6 SWOT Analysis 9 Chronic Obstructive Pulmonary Disorder (COPD) Related Market Analysis 9.1 Upstream Analysis 9.1.1 Macro Analysis of Upstream Markets 9.1.2 Key Players in Upstream Markets 9.1.3 Upstream Market Trend Analysis 9.1.4 Chronic Obstructive Pulmonary Disorder (COPD) Manufacturing Cost Analysis 9.2 Downstream Market Analysis 9.2.1 Macro Analysis of Down Markets 9.2.2 Key Players in Down Markets 9.2.3 Downstream Market Trend Analysis 9.2.4 Sales Channel, Distributors, Traders and Dealers 10 Research Findings and Conclusion

List of Tables and Figures Figure Product Picture Chronic Obstructive Pulmonary Disorder (COPD) Figure Market Concentration Ratio and Market Maturity Analysis of Chronic Obstructive Pulmonary Disorder (COPD) Figure Bottom-up and Top-down Approaches for This Report Figure Part of Our External Database Figure Part of Our External Database Figure Key Executives Interviewed Table Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Big Type Figure Global Market Share of Chronic Obstructive Pulmonary Disorder (COPD) by Big Type in 2021 Figure Corticosteroids Picture (2017-2022) Figure Phosphodiesterase Type 4 Inhibitors Picture (2017-2022) Figure Bronchodilators Picture (2017-2022) Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Big Application Table Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Big Application in 2021 Figure Hospital Picture Figure Clinic Picture Figure Retail Pharmacies Picture Figure Other Picture Table Global Chronic Obstructive Pulmonary Disorder (COPD) Comparison by Regions (M USD) （2017-2027） Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size (Million US$) (2017-2027) Figure North America Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate (2017-2027) Figure Europe Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate (2017-2027) Figure China Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate (2017-2027) Figure Japan Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate (2017-2027) Figure Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate (2017-2027) Table Business Impact Assessment - Covid-19 Table Market Trends and Chronic Obstructive Pulmonary Disorder (COPD) Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales by Manufacturer (2017-2022) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Market Share by Manufacturer in 2021 Table Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Manufacturer (2017-2022) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Manufacturer in 2021 Table Global Chronic Obstructive Pulmonary Disorder (COPD) Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Chronic Obstructive Pulmonary Disorder (COPD) Manufacturer (Revenue) Market Share in 2021 Figure Top 10 Chronic Obstructive Pulmonary Disorder (COPD) Manufacturer (Revenue) Market Share in 2021 Table Date of Key Manufacturers Enter into Chronic Obstructive Pulmonary Disorder (COPD) Market Table Key Manufacturers Chronic Obstructive Pulmonary Disorder (COPD) Product Type Table Mergers & Acquisitions Planning Table AstraZeneca Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of AstraZeneca Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022 Table Company One Main Business Table Company One Recent Development Table Boehringer Ingelheim International GmbH Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of Boehringer Ingelheim International GmbH Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Boehringer Ingelheim International GmbH Recent Development Table GlaxoSmithKline Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of GlaxoSmithKline Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table GlaxoSmithKline Main Business Table GlaxoSmithKline Recent Development Table Novartis AG Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of Novartis AG Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Novartis AG Main Business Table Novartis AG Recent Development Table Novartis AG Main Business Table Novartis AG Recent Development Table Teva Pharmaceutical Industries Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of Teva Pharmaceutical Industries Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Teva Pharmaceutical Industries Main Business Table Teva Pharmaceutical Industries Recent Development Table Sunovion Pharmaceuticals Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of Sunovion Pharmaceuticals Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Sunovion Pharmaceuticals Main Business Table Sunovion Pharmaceuticals Recent Development Table CHIESI Farmaceutici Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of CHIESI Farmaceutici Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table CHIESI Farmaceutici Main Business Table CHIESI Farmaceutici Recent Development Table Orion Corporation Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of Orion Corporation Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Orion Corporation Main Business Table Orion Corporation Recent Development Table ​Mylan Company Profile Table Chronic Obstructive Pulmonary Disorder (COPD) Product Introduction, Application and Specification of ​Mylan Table Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table ​Mylan Main Business Table ​Mylan Recent Development Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2017-2022) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Growth Rate (2017-2022) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales by Regions (2017-2022) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Market Share by Regions in 2021 Table Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Regions (2017-2022) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Regions in 2021 Figure North America Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2017-2022) Figure Europe Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2017-2022) Figure China Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2017-2022) Figure Japan Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2017-2022) Figure Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2017-2022) Figure Other Regions Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2017-2022) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales by Big Type (2017-2022) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Market Share by Big Type (2017-2022) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Market Share by Big Type in 2019 Table Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Big Type (2017-2022) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Big Type (2017-2022) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Big Type in 2019 Figure Global Corticosteroids Sales Growth Rate (2017-2022) Figure Global Corticosteroids Price (2017-2022) Figure Global Phosphodiesterase Type 4 Inhibitors Sales Growth Rate (2017-2022) Figure Global Phosphodiesterase Type 4 Inhibitors Price (2017-2022) Figure Global Bronchodilators Sales Growth Rate (2017-2022) Figure Global Bronchodilators Price (2017-2022) Figure Global Others Sales Growth Rate (2017-2022) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales by Big Application (2017-2022) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Market Share by Big Application (2017-2022) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Market Share by Big Application in 2019 Figure Global Hospital Sales Growth Rate (2017-2022) Figure Global Clinic Sales Growth Rate (2017-2022) Figure Global Retail Pharmacies Sales Growth Rate (2017-2022) Figure Global Other Sales Growth Rate (2017-2022) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Sales and Growth Rate (2022-2027) Figure Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue and Growth Rate (2022-2027) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Forecast by Regions (2022-2027) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share Forecast by Regions (2022-2027) Figure North America Sales Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) Figure Europe Sales Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) Figure China Sales Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) Figure Japan Sales Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) Figure Southeast Asia Sales Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) Figure Other Regions Sales Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast (2022-2027) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Forecast by Type (2022-2027) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share Forecast by Type (2022-2027) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Sales Forecast by Application (2022-2027) Table Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share Forecast by Application (2022-2027) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Chronic Obstructive Pulmonary Disorder (COPD) Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure North America Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Units) Growth Rate Forecast (2021-2025) Figure North America Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate Forecast (2021-2025) Figure Europe Chronic Obstructive Pulmonary Disorder (COPD) Sales (K Units) Growth Rate Forecast (2021-2025) Figure Europe Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate Forecast (2021-2025) Figure Japan Chronic Obstructive Pulmonary Disorder (COPD) Production (K Units) Growth Rate Forecast (2021-2025) Figure Japan Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate Forecast (2021-2025) Figure China Chronic Obstructive Pulmonary Disorder (COPD) Production (K Units) Growth Rate Forecast (2021-2025) Figure China Chronic Obstructive Pulmonary Disorder (COPD) Revenue (Million US$) Growth Rate Forecast (2021-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

AstraZeneca Boehringer Ingelheim International GmbH GlaxoSmithKline Novartis AG Teva Pharmaceutical Industries Sunovion Pharmaceuticals CHIESI Farmaceutici